Share Price and Basic Stock Data
Last Updated: February 25, 2025, 4:28 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Reliance Capital Ltd operates primarily in the finance and investments sector, demonstrating a volatile revenue trend over recent quarters. The company reported sales of ₹6,393 Cr for September 2023, an increase from ₹5,957 Cr in June 2023. This upward trajectory continued into December 2023 with sales recorded at ₹6,098 Cr. However, the company faced fluctuations in previous quarters, with sales dipping to ₹3,596 Cr in June 2022 before recovering. Annual sales figures reflect a broader trend, peaking at ₹24,247 Cr in March 2024, compared to ₹19,037 Cr in March 2023. This growth signals a recovery phase, yet it remains crucial to monitor the sustainability of these revenue levels given the company’s historical volatility.
Profitability and Efficiency Metrics
Reliance Capital’s profitability metrics depict a challenging landscape. The operating profit margin (OPM) stood at a mere 6% as of the latest reporting, reflecting substantial pressure on the company’s earnings. The net profit reported for the trailing twelve months (TTM) was ₹827 Cr, a recovery from losses in prior periods, including a net loss of ₹1,759 Cr in March 2023. Efficiency ratios illustrate mixed results; the interest coverage ratio (ICR) was strong at 16.26x, indicating the company can comfortably meet its interest obligations. However, the return on equity (ROE) remains unreported, suggesting ongoing concerns regarding shareholder returns. The cash conversion cycle (CCC) at 20 days indicates effective management of working capital, although historical highs of 48 days in March 2023 raised concerns about liquidity management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Reliance Capital reveals significant challenges, particularly in terms of reserves and borrowings. The company reported reserves of -₹10,757 Cr, indicating a substantial deficit that raises concerns about financial stability. Total borrowings stood at ₹17,601 Cr, maintaining a high leverage ratio that could pose risks in adverse market conditions. The current ratio at 0.83 suggests liquidity constraints, below the typical sector range of 1.5 to 2.0, indicating potential difficulties in covering short-term liabilities. Furthermore, the price-to-book value (P/BV) stands at 0.00x, reflecting investor skepticism regarding the company’s fundamental value. Despite these challenges, the enterprise value (EV) reported at ₹0.00 suggests a potential market reassessment may be necessary.
Shareholding Pattern and Investor Confidence
The shareholding structure of Reliance Capital illustrates a dominant public ownership of 95.47%, with institutional investors holding a minimal stake; foreign institutional investors (FIIs) reported at 0.00%, and domestic institutional investors (DIIs) at 2.99%. This lack of institutional confidence may be linked to the company’s financial instability and historical performance issues. The promoters’ shareholding has remained stagnant at 0.89%, raising questions about their commitment and confidence in the company’s future. This high public ownership could indicate a retail-driven investor base, often more susceptible to market volatility. The number of shareholders stood at 7,48,150, suggesting a broad interest, yet the lack of institutional backing may hinder the stock’s potential for recovery and stability.
Outlook, Risks, and Final Insight
The outlook for Reliance Capital remains cautiously optimistic, contingent on its ability to stabilize profitability and improve balance sheet metrics. Key strengths include a robust interest coverage ratio, indicating capacity to service debt, and a recent upward trend in sales. However, significant risks persist, including negative reserves, high leverage, and a lack of institutional investor confidence. The company must navigate these challenges effectively to regain market trust. Future scenarios could involve further recovery in profitability and revenue stabilization if operational efficiencies are realized, or continued volatility if financial pressures persist. The management’s strategic initiatives in addressing these issues will be critical in determining the company’s trajectory moving forward.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.8 Cr. | 40.3 | 57.0/36.4 | 47.3 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,183 Cr. | 275 | 455/269 | 13.6 | 111 | 0.36 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 28.1 Cr. | 0.40 | 1.13/0.38 | 3.89 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.75 Cr. | 7.58 | 11.6/7.58 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 16.1 Cr. | 31.4 | 69.9/31.4 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,083.86 Cr | 1,252.85 | 66.88 | 4,368.01 | 0.38% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,993 | 4,076 | 4,763 | 3,596 | 5,796 | 5,218 | 4,427 | 5,957 | 6,393 | 6,098 | 5,800 | 6,517 | 7,343 |
| Expenses | 6,411 | 5,230 | 8,674 | 3,766 | 5,712 | 5,167 | 5,914 | 5,535 | 6,644 | 5,879 | 5,756 | 6,167 | 6,923 |
| Operating Profit | -418 | -1,154 | -3,911 | -170 | 84 | 51 | -1,487 | 423 | -251 | 218 | 45 | 350 | 419 |
| OPM % | -7% | -28% | -82% | -5% | 1% | 1% | -34% | 7% | -4% | 4% | 1% | 5% | 6% |
| Other Income | 8 | 7 | 113 | 13 | 251 | 9 | 9 | 47 | 30 | 20 | 109 | 14 | 17 |
| Interest | 677 | 563 | 278 | 271 | 15 | 6 | 8 | -1 | 8 | 22 | 9 | 13 | 13 |
| Depreciation | 28 | 28 | 30 | 30 | 31 | 28 | 27 | 26 | 27 | 29 | 32 | 30 | 30 |
| Profit before tax | -1,115 | -1,738 | -4,106 | -458 | 290 | 27 | -1,513 | 444 | -256 | 187 | 112 | 321 | 393 |
| Tax % | 4% | 1% | 1% | 7% | 26% | 41% | -1% | 2% | -7% | 57% | -48% | 15% | 21% |
| Net Profit | -1,156 | -1,759 | -4,132 | -491 | 215 | 16 | -1,499 | 434 | -239 | 81 | 166 | 272 | 309 |
| EPS in Rs | -47.07 | -70.16 | -165.03 | -18.27 | 7.38 | -0.03 | -59.46 | 15.60 | -10.40 | 1.56 | 2.44 | 8.36 | 9.02 |
Last Updated: February 28, 2025, 6:18 pm
Below is a detailed analysis of the quarterly data for Reliance Capital Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Sales, as of Sep 2024, the value is 7,343.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,517.00 Cr. (Jun 2024) to 7,343.00 Cr., marking an increase of 826.00 Cr..
- For Expenses, as of Sep 2024, the value is 6,923.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,167.00 Cr. (Jun 2024) to 6,923.00 Cr., marking an increase of 756.00 Cr..
- For Operating Profit, as of Sep 2024, the value is 419.00 Cr.. The value appears strong and on an upward trend. It has increased from 350.00 Cr. (Jun 2024) to 419.00 Cr., marking an increase of 69.00 Cr..
- For OPM %, as of Sep 2024, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Jun 2024) to 6.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2024, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Jun 2024) to 17.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Sep 2024, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 13.00 Cr..
- For Depreciation, as of Sep 2024, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 30.00 Cr..
- For Profit before tax, as of Sep 2024, the value is 393.00 Cr.. The value appears strong and on an upward trend. It has increased from 321.00 Cr. (Jun 2024) to 393.00 Cr., marking an increase of 72.00 Cr..
- For Tax %, as of Sep 2024, the value is 21.00%. The value appears to be increasing, which may not be favorable. It has increased from 15.00% (Jun 2024) to 21.00%, marking an increase of 6.00%.
- For Net Profit, as of Sep 2024, the value is 309.00 Cr.. The value appears strong and on an upward trend. It has increased from 272.00 Cr. (Jun 2024) to 309.00 Cr., marking an increase of 37.00 Cr..
- For EPS in Rs, as of Sep 2024, the value is 9.02. The value appears strong and on an upward trend. It has increased from 8.36 (Jun 2024) to 9.02, marking an increase of 0.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:20 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,448 | 7,467 | 8,900 | 9,941 | 17,507 | 18,725 | 20,453 | 18,327 | 19,251 | 19,272 | 19,037 | 24,247 | 25,758 |
| Expenses | 4,283 | 4,128 | 4,982 | 5,368 | 12,901 | 18,851 | 17,346 | 20,364 | 25,550 | 24,878 | 20,522 | 23,764 | 24,726 |
| Operating Profit | 3,165 | 3,339 | 3,918 | 4,573 | 4,606 | -126 | 3,107 | -2,037 | -6,299 | -5,607 | -1,486 | 484 | 1,032 |
| OPM % | 42% | 45% | 44% | 46% | 26% | -1% | 15% | -11% | -33% | -29% | -8% | 2% | 4% |
| Other Income | 69 | 77 | 74 | 57 | 133 | 158 | 225 | 4,931 | 58 | 30 | 281 | 206 | 160 |
| Interest | 2,348 | 2,508 | 2,648 | 2,828 | 3,084 | 4,112 | 4,541 | 3,994 | 2,768 | 2,218 | 334 | 88 | 58 |
| Depreciation | 56 | 61 | 68 | 70 | 116 | 94 | 123 | 123 | 105 | 112 | 116 | 114 | 121 |
| Profit before tax | 830 | 847 | 1,276 | 1,732 | 1,539 | -4,174 | -1,332 | -1,223 | -9,114 | -7,908 | -1,654 | 487 | 1,013 |
| Tax % | 15% | 19% | 18% | 22% | 19% | 9% | 9% | -2% | 2% | 2% | 6% | 9% | |
| Net Profit | 874 | 844 | 1,131 | 1,265 | 1,248 | -4,556 | -1,454 | -1,199 | -9,287 | -8,055 | -1,759 | 442 | 827 |
| EPS in Rs | 33.06 | 30.42 | 39.63 | 43.59 | 42.99 | -183.38 | -59.87 | -42.54 | -372.10 | -321.15 | -70.38 | 9.20 | 21.38 |
| Dividend Payout % | 45% | 36% | 23% | 23% | 24% | -6% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -3.43% | 34.00% | 11.85% | -1.34% | -465.06% | 68.09% | 17.54% | -674.56% | 13.27% | 78.16% | 125.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 37.44% | -22.16% | -13.19% | -463.72% | 533.15% | -50.55% | -692.10% | 687.83% | 64.90% | 46.97% |
Reliance Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 3% |
| 3 Years: | 8% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | 17% |
| 3 Years: | 27% |
| TTM: | 139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -27% |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 11:25 am
Balance Sheet
Last Updated: December 14, 2024, 3:07 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 246 | 244 | 253 | 253 | 253 | 253 | 253 | 253 | 253 | 253 | 253 | 253 | 253 |
| Reserves | 11,725 | 12,147 | 13,071 | 13,890 | 15,081 | 760 | -1,202 | -2,547 | -11,791 | -20,073 | -12,319 | -11,381 | -10,757 |
| Borrowings | 22,510 | 25,577 | 26,139 | 28,035 | 39,261 | 46,357 | 46,160 | 26,909 | 26,887 | 26,839 | 17,650 | 17,600 | 17,601 |
| Other Liabilities | 6,107 | 7,560 | 7,977 | 24,934 | 28,006 | 35,809 | 38,762 | 40,162 | 49,528 | 56,671 | 68,022 | 68,514 | 75,255 |
| Total Liabilities | 40,588 | 45,528 | 47,440 | 67,112 | 82,601 | 83,179 | 83,973 | 64,777 | 64,876 | 63,689 | 73,607 | 74,987 | 82,352 |
| Fixed Assets | 434 | 482 | 530 | 5,512 | 5,745 | 5,726 | 5,699 | 5,546 | 5,577 | 5,582 | 5,263 | 5,314 | 5,319 |
| CWIP | 5 | 1 | 2 | 3 | 3 | 34 | 18 | 19 | 20 | 15 | 16 | 24 | 5 |
| Investments | 15,087 | 16,157 | 15,881 | 25,279 | 34,652 | 33,300 | 32,672 | 34,594 | 39,755 | 44,014 | 48,524 | 56,688 | 60,644 |
| Other Assets | 25,062 | 28,888 | 31,027 | 36,318 | 42,201 | 44,119 | 45,584 | 24,618 | 19,524 | 14,078 | 19,803 | 12,961 | 16,384 |
| Total Assets | 40,588 | 45,528 | 47,440 | 67,112 | 82,601 | 83,179 | 83,973 | 64,777 | 64,876 | 63,689 | 73,607 | 74,987 | 82,352 |
Below is a detailed analysis of the balance sheet data for Reliance Capital Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 253.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 253.00 Cr..
- For Reserves, as of Sep 2024, the value is -10,757.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -11,381.00 Cr. (Mar 2024) to -10,757.00 Cr., marking an improvement of 624.00 Cr..
- For Borrowings, as of Sep 2024, the value is 17,601.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 17,600.00 Cr. (Mar 2024) to 17,601.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is 75,255.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68,514.00 Cr. (Mar 2024) to 75,255.00 Cr., marking an increase of 6,741.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is 82,352.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74,987.00 Cr. (Mar 2024) to 82,352.00 Cr., marking an increase of 7,365.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is 5,319.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,314.00 Cr. (Mar 2024) to 5,319.00 Cr., marking an increase of 5.00 Cr..
- For CWIP, as of Sep 2024, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 19.00 Cr..
- For Investments, as of Sep 2024, the value is 60,644.00 Cr.. The value appears strong and on an upward trend. It has increased from 56,688.00 Cr. (Mar 2024) to 60,644.00 Cr., marking an increase of 3,956.00 Cr..
- For Other Assets, as of Sep 2024, the value is 16,384.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,961.00 Cr. (Mar 2024) to 16,384.00 Cr., marking an increase of 3,423.00 Cr..
- For Total Assets, as of Sep 2024, the value is 82,352.00 Cr.. The value appears strong and on an upward trend. It has increased from 74,987.00 Cr. (Mar 2024) to 82,352.00 Cr., marking an increase of 7,365.00 Cr..
However, the Borrowings (17,601.00 Cr.) are higher than the Reserves (-10,757.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -19.00 | -22.00 | -23.00 | -24.00 | -35.00 | -172.00 | -43.00 | -28.00 | -32.00 | -31.00 | -18.00 | 467.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 41 | 46 | 14 | 27 | 19 | 17 | 14 | 22 | 29 | 35 | 48 | 20 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 41 | 46 | 14 | 27 | 19 | 17 | 14 | 22 | 29 | 35 | 48 | 20 |
| Working Capital Days | -254 | -469 | -215 | -331 | -227 | -607 | -596 | -636 | -722 | -862 | -1,078 | -845 |
| ROCE % | 10% | 9% | 10% | 11% | 9% | -0% | 7% | 8% | -31% | -48% | -19% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.59 | -70.07 | -320.80 | -369.82 | -47.79 |
| Diluted EPS (Rs.) | 17.59 | -70.07 | -320.80 | -369.82 | -47.79 |
| Cash EPS (Rs.) | 21.58 | -65.12 | -300.69 | -332.73 | -42.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -439.40 | -443.41 | -751.23 | -426.92 | -66.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -439.40 | -443.41 | -751.23 | -426.92 | -66.13 |
| Revenue From Operations / Share (Rs.) | 957.49 | 751.73 | 761.01 | 760.87 | 724.23 |
| PBDIT / Share (Rs.) | 24.90 | -49.15 | -208.41 | -217.55 | -80.51 |
| PBIT / Share (Rs.) | 20.39 | -53.72 | -212.85 | -221.70 | -85.38 |
| PBT / Share (Rs.) | 18.85 | -65.55 | -299.32 | -330.04 | -48.54 |
| Net Profit / Share (Rs.) | 17.06 | -69.70 | -305.12 | -336.88 | -47.59 |
| NP After MI And SOA / Share (Rs.) | 9.18 | -70.23 | -320.47 | -371.70 | -42.49 |
| PBDIT Margin (%) | 2.60 | -6.53 | -27.38 | -28.59 | -11.11 |
| PBIT Margin (%) | 2.12 | -7.14 | -27.96 | -29.13 | -11.78 |
| PBT Margin (%) | 1.96 | -8.71 | -39.33 | -43.37 | -6.70 |
| Net Profit Margin (%) | 1.78 | -9.27 | -40.09 | -44.27 | -6.57 |
| NP After MI And SOA Margin (%) | 0.95 | -9.34 | -42.11 | -48.85 | -5.86 |
| Return on Networth / Equity (%) | -2.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | -7.05 | -2.20 | -347.85 | -58.51 | -11.75 |
| Return On Assets (%) | 0.31 | -2.68 | -12.74 | -14.49 | -1.65 |
| Long Term Debt / Equity (X) | 0.00 | -1.36 | -0.92 | -1.59 | -7.95 |
| Total Debt / Equity (X) | -1.58 | -1.46 | -1.35 | -2.33 | -11.73 |
| Asset Turnover Ratio (%) | 0.34 | 0.29 | 0.00 | 0.01 | 0.02 |
| Current Ratio (X) | 0.83 | 12.81 | 0.92 | 1.06 | 1.25 |
| Quick Ratio (X) | 0.83 | 12.81 | 0.92 | 1.06 | 1.25 |
| Interest Coverage Ratio (X) | 16.26 | -4.16 | -2.41 | -2.01 | -0.51 |
| Interest Coverage Ratio (Post Tax) (X) | 12.14 | -4.89 | -2.53 | -2.11 | -0.53 |
| Enterprise Value (Cr.) | 0.00 | 17888.36 | 26486.24 | 26866.23 | 26705.60 |
| EV / Net Operating Revenue (X) | 0.00 | 0.93 | 1.37 | 1.40 | 1.46 |
| EV / EBITDA (X) | 0.00 | -14.37 | -5.02 | -4.88 | -13.11 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 |
| Price / BV (X) | 0.00 | -0.01 | -0.02 | -0.02 | -0.04 |
| Price / Net Operating Revenue (X) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 |
| EarningsYield | 0.00 | -8.76 | -19.25 | -34.54 | -9.46 |
After reviewing the key financial ratios for Reliance Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 17.59. This value is within the healthy range. It has increased from -70.07 (Mar 23) to 17.59, marking an increase of 87.66.
- For Diluted EPS (Rs.), as of Mar 24, the value is 17.59. This value is within the healthy range. It has increased from -70.07 (Mar 23) to 17.59, marking an increase of 87.66.
- For Cash EPS (Rs.), as of Mar 24, the value is 21.58. This value is within the healthy range. It has increased from -65.12 (Mar 23) to 21.58, marking an increase of 86.70.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -439.40. It has increased from -443.41 (Mar 23) to -439.40, marking an increase of 4.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -439.40. It has increased from -443.41 (Mar 23) to -439.40, marking an increase of 4.01.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 957.49. It has increased from 751.73 (Mar 23) to 957.49, marking an increase of 205.76.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 24.90. This value is within the healthy range. It has increased from -49.15 (Mar 23) to 24.90, marking an increase of 74.05.
- For PBIT / Share (Rs.), as of Mar 24, the value is 20.39. This value is within the healthy range. It has increased from -53.72 (Mar 23) to 20.39, marking an increase of 74.11.
- For PBT / Share (Rs.), as of Mar 24, the value is 18.85. This value is within the healthy range. It has increased from -65.55 (Mar 23) to 18.85, marking an increase of 84.40.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 17.06. This value is within the healthy range. It has increased from -69.70 (Mar 23) to 17.06, marking an increase of 86.76.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.18. This value is within the healthy range. It has increased from -70.23 (Mar 23) to 9.18, marking an increase of 79.41.
- For PBDIT Margin (%), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 10. It has increased from -6.53 (Mar 23) to 2.60, marking an increase of 9.13.
- For PBIT Margin (%), as of Mar 24, the value is 2.12. This value is below the healthy minimum of 10. It has increased from -7.14 (Mar 23) to 2.12, marking an increase of 9.26.
- For PBT Margin (%), as of Mar 24, the value is 1.96. This value is below the healthy minimum of 10. It has increased from -8.71 (Mar 23) to 1.96, marking an increase of 10.67.
- For Net Profit Margin (%), as of Mar 24, the value is 1.78. This value is below the healthy minimum of 5. It has increased from -9.27 (Mar 23) to 1.78, marking an increase of 11.05.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 8. It has increased from -9.34 (Mar 23) to 0.95, marking an increase of 10.29.
- For Return on Networth / Equity (%), as of Mar 24, the value is -2.09. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 23) to -2.09, marking a decrease of 2.09.
- For Return on Capital Employeed (%), as of Mar 24, the value is -7.05. This value is below the healthy minimum of 10. It has decreased from -2.20 (Mar 23) to -7.05, marking a decrease of 4.85.
- For Return On Assets (%), as of Mar 24, the value is 0.31. This value is below the healthy minimum of 5. It has increased from -2.68 (Mar 23) to 0.31, marking an increase of 2.99.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -1.36 (Mar 23) to 0.00, marking an increase of 1.36.
- For Total Debt / Equity (X), as of Mar 24, the value is -1.58. This value is within the healthy range. It has decreased from -1.46 (Mar 23) to -1.58, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.34. It has increased from 0.29 (Mar 23) to 0.34, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 24, the value is 0.83. This value is below the healthy minimum of 1.5. It has decreased from 12.81 (Mar 23) to 0.83, marking a decrease of 11.98.
- For Quick Ratio (X), as of Mar 24, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 12.81 (Mar 23) to 0.83, marking a decrease of 11.98.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 16.26. This value is within the healthy range. It has increased from -4.16 (Mar 23) to 16.26, marking an increase of 20.42.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 12.14. This value is within the healthy range. It has increased from -4.89 (Mar 23) to 12.14, marking an increase of 17.03.
- For Enterprise Value (Cr.), as of Mar 24, the value is 0.00. It has decreased from 17,888.36 (Mar 23) to 0.00, marking a decrease of 17,888.36.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 23) to 0.00, marking a decrease of 0.93.
- For EV / EBITDA (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -14.37 (Mar 23) to 0.00, marking an increase of 14.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
- For Price / BV (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -0.01 (Mar 23) to 0.00, marking an increase of 0.01.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
- For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -8.76 (Mar 23) to 0.00, marking an increase of 8.76.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Reliance Capital Ltd:
- Net Profit Margin: 1.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -7.05% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -2.09% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.14
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0.58 (Industry average Stock P/E: 66.88)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.78%
Fundamental Analysis of Reliance Capital Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | Kamala Mills Compound, Mumbai Maharashtra 400013 | rcl.investor@relianceada.com http://www.reliancecapital.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Dhirubhai Ambani | Chairman, Non Ind & Non Exe Director |
| Ms. Chhaya Virani | Ind. Non-Executive Director |
| Mr. Angarai Natarajan Sethuraman | Non Exe.Non Ind.Director |
| Mr. Rahul Sarin | Ind. Non-Executive Director |
| Dr. Thomas Mathew | Ind. Non-Executive Director |
Reliance Capital Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹11.79 |
| Previous Day | ₹11.79 |
FAQ
What is the intrinsic value of Reliance Capital Ltd?
Reliance Capital Ltd's intrinsic value (as of 29 January 2026) is ₹97.60 which is 687.10% higher the current market price of ₹12.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹312 Cr. market cap, FY2025-2026 high/low of ₹/, reserves of ₹-10,757 Cr, and liabilities of ₹82,352 Cr.
What is the Market Cap of Reliance Capital Ltd?
The Market Cap of Reliance Capital Ltd is 312 Cr..
What is the current Stock Price of Reliance Capital Ltd as on 29 January 2026?
The current stock price of Reliance Capital Ltd as on 29 January 2026 is ₹12.4.
What is the High / Low of Reliance Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Reliance Capital Ltd stocks is ₹/.
What is the Stock P/E of Reliance Capital Ltd?
The Stock P/E of Reliance Capital Ltd is 0.58.
What is the Book Value of Reliance Capital Ltd?
The Book Value of Reliance Capital Ltd is 416.
What is the Dividend Yield of Reliance Capital Ltd?
The Dividend Yield of Reliance Capital Ltd is 0.00 %.
What is the ROCE of Reliance Capital Ltd?
The ROCE of Reliance Capital Ltd is 8.16 %.
What is the ROE of Reliance Capital Ltd?
The ROE of Reliance Capital Ltd is %.
What is the Face Value of Reliance Capital Ltd?
The Face Value of Reliance Capital Ltd is 10.0.